ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Sinovac Biotech Co., Ltd clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 163 studies whose lead sponsor is Sinovac Biotech Co., Ltd or one of 5 companies grouped under it. 36 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 6 registry names, not the registry’s. See them and correct one ↓

Compare Sinovac Biotech with CanSino Biologics and GlaxoSmithKline →

Pipeline: 32 programs

Each counted once: 32 with a study Sinovac Biotech Co., Ltd leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 5 of 11 with the most live studies.

Program
Sinovac PCV13Phase 3 · 3 live · Pneumococcal Infections · primary completion Mar 2027☆ Track
Rabies Vaccine (Serum-free Vero Cell), Freeze-driedPhase 3 · 2 live · Rabies · primary completion Dec 2026☆ Track
low dose Bivalent Enterovirus Vaccine (Vero Cell), InactivatedPhase 3 · 1 live · Hand, Foot and Mouth Disease☆ Track
Sinovac rabies vaccinePhase 3 · 1 live · Rabies☆ Track
SNA02-48Phase 3 · 1 live · Tetanus · primary completion Mar 2027☆ Track

6 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Sinovac Biotech Co., Ltd’s own registered studies; Sinovac Biotech Co., Ltd’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Sinovac Biotech Co., Ltd’s studies test, most open studies first — 10 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

15 of Sinovac Biotech Co., Ltd’s studies under way reach primary completion within a year, 10 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 2N’26
  2. 2D
  3. 3J’27
  4. 1F
  5. 2M
  6. 2A
  7. 1M
  8. J
  9. 1J
  10. A
  11. 1S
  12. O
  13. N

Add all 15 to your calendar (.ics) → With an account.

All 163 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now3622%Recruiting 18 · Not yet recruiting 15 · Enrolling by invitation 3
  • Under way, not recruiting74%
  • Completed10564%
  • Stopped early53%Withdrawn 3 · Suspended 2
  • Status unknown or other106%

Phase

Where

  • China137
  • Philippines6
  • Pakistan4
  • Vietnam3
  • Chile2
  • Turkey2

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 2521
  16. 22
  17. 23
  18. 24
  19. 25
  20. 2226

By the year each study started; 2 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Sinovac Biotech Co., Ltd.

  • Sinovac Biotech Co., Ltd
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    93 studies
  • Sinovac Life Sciences Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    26 studies →
  • Sinovac Research and Development Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    22 studies →
  • Sinovac (Dalian) Vaccine Technology Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    20 studies →
  • Sinovac Biotech (Hong Kong) Limited
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Sinovac Biotech (Colombia) S.A.S.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Sinovac Biotech Co., Ltd leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 163. Browse all 163 →